title: Synthesis and pharmacological properties of novel hydrophilic 5-HT4 receptor antagonists.
abstract: Serotonin (5-hydroxytryptamine, 5-HT) is an important signalling molecule in the human body. The 5-HT(4) serotonin receptor, coupled to the G protein G(s), plays important physiological and pathophysiological roles in the heart, urinary bladder, gastrointestinal tract and the adrenal gland. Both 5-HT(4) antagonists and agonists have been developed in the aim to treat diseases in these organs. 5-HT(4) agonists might have beneficial effects in the central nervous system (CNS) and therefore, 5-HT(4) antagonists might cause CNS side effects. In this study, we have developed new amphoteric 5-HT(4) antagonists. A series of cyclic indole amide derivatives possessing an oxazine ring and a piperidine alkane carboxylic acid side chain and the corresponding prodrug esters were synthesized and their binding to 5-HT(4) receptors and antagonist properties were evaluated. In addition, an indole ester without the oxazine ring and the corresponding indole amide derivatives were also tested. Octanol-water distribution (LogD(Oct7.4)) was tested for some of the synthesized ligands. The main structure-affinity characteristics of the 5-HT(4) compounds tested were that the prodrug esters show higher affinity than their corresponding free acids, indole esters show higher affinity than the corresponding amides and ligands containing the oxazine ring in the indole skeleton show higher affinity than indole derivatives not containing the ring. One representative prodrug ester and its corresponding free acid were tested for binding on a panel of receptors and showed preserved selectivity for the 5-HT(4) receptor. These new molecules may be useful to target peripheral 5-HT(4) receptors.
authors.affiliation: Drug Discovery Laboratory AS, Oslo Research Park, Oslo, Norway.
authors.forename: Bjarne
authors.initials: B
authors.lastname: Brudeli
authors.forename: Lise Román
authors.initials: LR
authors.lastname: Moltzau
authors.forename: Kjetil Wessel
authors.initials: KW
authors.lastname: Andressen
authors.forename: Kurt A
authors.initials: KA
authors.lastname: Krobert
authors.forename: Jo
authors.initials: J
authors.lastname: Klaveness
authors.forename: Finn Olav
authors.initials: FO
authors.lastname: Levy
mesh_terms: D000577:Amides; D004952:Esters; D006801:Humans; D007211:Indoles; D008024:Ligands; D010078:Oxazines; D010880:Piperidines; D011355:Prodrugs / Q000138:chemical synthesis; D044422:Receptors, Serotonin, 5-HT4 / Q000378:metabolism*; D058832:Serotonin 5-HT4 Receptor Antagonists / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D013329:Structure-Activity Relationship
chemical_list: D000577:Amides; D004952:Esters; D007211:Indoles; D008024:Ligands; D010078:Oxazines; D010880:Piperidines; D011355:Prodrugs; D058832:Serotonin 5-HT4 Receptor Antagonists; D044422:Receptors, Serotonin, 5-HT4; C032727:piperidine